Genmab A/S (GMAB)

Genmab Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14,670	14,867	9,893	8,957	7,260	3,552
Short-Term Investments	14,914	13,268	12,431	10,381	8,819	7,419
Cash & Cash Equivalents	29,584	28,135	22,324	19,338	16,079	10,971
Cash Growth	20.53%	26.03%	15.44%	20.27%	46.56%	79.68%
Receivables	4,742	5,009	5,760	3,394	2,483	3,001
Inventory	106	57	0	0	0	0
Other Current Assets	-63	-62	134	4	229	-11
Total Current Assets	34,369	33,139	28,218	22,736	18,791	13,961
Property, Plant & Equipment	1,860	1,641	1,322	975	736	414
Long-Term Investments	153	134	133	371	1,081	149
Goodwill and Intangibles	23	101	146	254	338	470
Other Long-Term Assets	275	274	300	291	197	150
Total Long-Term Assets	2,311	2,150	1,901	1,891	2,352	1,183
Total Assets	36,680	35,289	30,119	24,627	21,143	15,144
Accounts Payable	2,538	2,342	1,727	1,493	1,186	840
Deferred Revenue	513	513	513	513	513	0
Current Debt	92	90	74	62	42	26
Other Current Liabilities	-384	-461	-491	-500	-488	72
Total Current Liabilities	2,759	2,484	1,823	1,568	1,253	938
Long-Term Debt	918	680	523	363	277	155
Other Long-Term Liabilities	506	515	491	500	492	3
Total Long-Term Liabilities	1,424	1,195	1,014	863	769	158
Total Liabilities	4,183	3,679	2,837	2,431	2,022	1,096
Total Debt	1,010	770	597	425	319	181
Debt Growth	21.83%	28.98%	40.47%	33.23%	76.24%	-
Retained Earnings	19,803	19,023	14,809	10,020	7,107	2,130
Shareholders' Equity	32,497	31,610	27,282	22,196	19,121	14,048
Net Cash / Debt	28,574	27,365	21,727	18,913	15,760	10,790
Net Cash / Debt Growth	20.49%	25.95%	14.88%	20.01%	46.06%	76.71%
Working Capital	31,610	30,655	26,395	21,168	17,538	13,023
Book Value Per Share	49.18	47.84	41.44	33.83	29.38	21.85

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).